Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 4/20 | 0.64 |
| ▸ | KDR | P35968 | 3/20 | 0.64 |
| ▸ | MKNK2 | Q9HBH9 | 6/20 | 0.61 |
| ▸ | MKNK1 | Q9BUB5 | 5/20 | 0.61 |
| ▸ | ABL1 | P00519 | 3/20 | 0.61 |
| ▸ | BCR | P11274 | 3/20 | 0.61 |
| ▸ | KIT | P10721 | 5/20 | 0.59 |
| ▸ | HTT | P42858 | 3/20 | 0.58 |
| ▸ | CLK1 | P49759 | 2/20 | 0.58 |
| ▸ | BRAF | P15056 | 2/20 | 0.57 |
| ▸ | STK25 | O00506 | 1/20 | 0.57 |
| ▸ | CIT | O14578 | 1/20 | 0.57 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.57 |
| ▸ | IKBKB | O14920 | 1/20 | 0.57 |
| ▸ | AURKA | O14965 | 1/20 | 0.57 |
| ▸ | GAK | O14976 | 1/20 | 0.57 |
| ▸ | CHUK | O15111 | 1/20 | 0.57 |
| ▸ | MUSK | O15146 | 1/20 | 0.57 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.57 |
| ▸ | MAP3K13 | O43283 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20912769 | 0.90 | KIT (0.71) | ABL1KITBRAFEGFRSRC | |
| SCHEMBL30904911 | 0.90 | KIT (0.71) | ABL1KITBRAFEGFRSRC | |
| SCHEMBL17208644 | 0.90 | RET (0.64) | RETKDRMKNK2MKNK1ABL1 | |
| SCHEMBL14704589 | 0.90 | MKNK2 (0.65) | RETKDRMKNK2MKNK1ABL1 | |
| SCHEMBL16380144 | 0.89 | RET (0.63) | RETKDRMKNK2MKNK1ABL1 | |
| SCHEMBL3182950 | 0.89 | RET (0.63) | RETKDRMKNK2MKNK1ABL1 | |
| SCHEMBL15785403 | 0.89 | MKNK2 (0.65) | RETKDRMKNK2MKNK1ABL1 | |
| SCHEMBL2777943 | 0.89 | KIT (0.57) | RETKDRMKNK2MKNK1ABL1 | |
| SCHEMBL12516824 | 0.88 | RET (0.62) | RETKDRMKNK2MKNK1ABL1 | |
| SCHEMBL16587846 | 0.88 | RET (0.68) | RETKDRMKNK2MKNK1ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158394-A1 | NEK7 INHIBITORS | Halia Therapeutics, Inc. | 2024-05-16 | — | — | US | disclosed |
| WO-2024059200-A1 | NEK7 INHIBITORS | Halia Therapeutics, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |
| EP-4320127-A1 | NEK7 INHIBITORS | Halia Therapeutics, Inc. (US) | 2024-02-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240158394-A1 | NEK7 INHIBITORS | NEK7, NEK5, NEK1 | RET 2117/4885KDR 4752/4885MKNK2 169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.